ARCHIVES

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

Paul Okunieff Named Director At UF Shands Cancer Center

October 16, 2009

NIH Director Varmus Names President of Sloan-Kettering, Succeeding Mark

October 15, 1999

Historical Vs. Current Controls: Comparability, Ethical Issues Argued By Moertel, Freireich

April 20, 1979

Proposed HHS Conflict of Interest Rules May Require More Disclosure by Researchers

May 15, 2009

Brinker Again To Lead Komen As CEO

December 11, 2009

Consensus Conference Recommends Adjuvant Chemotherapy In Breast Cancer Only For Premenopausal Women

July 25, 1980